TABLE 3. Influenza vaccine: Recommended dosage and route, by age, for the 2012-2013 Season.

Age group	TIV without adjuvant†	MF59 -adjuvanted TIV (Fluad®)	TIV for intradermal use (Intanza®)	LAIV (FluMist®)	Number of doses required
	IM	IM	ID	IN
6-23 months	0.5 mL2	-	-	-	1 or 2*
2-8 years	0.5 mL	-	-	0.2 mL (0.1 mL per nostril)	1 or 2*
9-17 years	0.5 mL	-	-	0.2 mL (0.1 mL per nostril)	1
18-59 years	0.5 mL	-	0.1 mL (9 µg/strain)‡	0.2 mL (0.1 mL per nostril)	1
60-64 years	0.5 mL	-	0.1 mL (15 µg/strain)	-	1
≥65 years	0.5 mL	0.5 mL	0.1 mL (15 µg/strain)	-	1

IM=Intramuscular ID=Intradermal IN=intranasal

* Children 6 months to less than 9 years of age who have never received the seasonal influenza vaccine require two doses of influenza vaccine, with a minimum interval of four weeks between doses. Eligible children <9 years of age who have properly received one or more doses of seasonal influenza vaccine in the past should receive one dose per influenza vaccination season thereafter.

^† Influvac^® ≥ 18 years, Fluviral^® ≥ 6 months, Agriflu^® ≥ 6 months, Vaxigrip^® ≥ 6 months and Fluzone^® ≥ 6 months.

^‡ For adults with immune compromising conditions, the 15µg formulation should be considered to improve response.